Skip to content
University of Colorado DenverCU DenverUniversity of Colorado Anschutz Medical CampusCU Anschutz
  • Webmail
  • UCD Access
  • Canvas
  • Quick Links
 
 

Tools & Resources

  • Campus Directory
  • A-Z Index
  • Human Resources
  • University Policies
  • Auraria Library
  • Strauss Health Sciences Library

Schools & Colleges

CU Denver

  • College of Architecture and Planning
  • College of Arts & Media
  • Business School
  • School of Education & Human Development
  • College of Engineering, Design and Computing
  • College of Liberal Arts and Sciences
  • School of Public Affairs

CU Anschutz Medical Campus

  • School of Dental Medicine
  • Graduate School
  • School of Medicine
  • College of Nursing
  • Skaggs School of Pharmacy and Pharmaceutical Sciences
  • Colorado School of Public Health

CU Campuses

  • CU Anschutz Medical Campus
  • CU Boulder
  • CU Colorado Springs
  • CU Denver
  • CU Online
  • CU System

SPARK | REACH Colorado

  • Home
  • SPARK Awards
    • What We Fund
    • Application Process
    • Our Funding Sources
    • FAQs
    • Submit an Application
  • Who We Are
    • SPARK Fellows
    • External Review Board
    • SPARK Team
  • Events
    • SPARK Upcoming Events
    • SPARK Past Events
  • Get Involved
  • Resources
    • SPARK Documents
    • Applicant Support: Bootcamp Sessions
  • Contact Us
University Quick Links

Meet our SPARK Fellows

Joshua Thurman, MD

Email Address:JOSHUA.THURMAN@CUANSCHUTZ.EDU

  • Bio

Non-Invasive Detection of Tissue Inflammation Using Molecular Imaging

This project proposes to develop a targeted molecular imaging probe for the non-invasive detection of tissue inflammation in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases. The current diagnosis of lupus nephritis and other autoimmune diseases of the kidney requires invasive kidney biopsies, which have limitations and risks. The researchers aim to create a positron emission tomography (PET)-based imaging tool to assess inflammation in the kidneys and other parts of the body without the need for biopsies. This diagnostic method will be valuable for monitoring disease in SLE patients and guiding the use of new complement inhibitory drugs in various autoimmune diseases. The team consists of experienced investigators with expertise in inflammatory diseases and monoclonal antibody engineering, well-positioned to develop a humanized probe to detect tissue-bound C3d with high sensitivity and specificity. Collaborators: Felix Poppelaars, MD, PhD, Michael Holers, MD, Catherine Foss, PhD and Martin Pomper, MD

Learn more about Dr. Thurman

CU Innovations

CU Anschutz

Anschutz Health Sciences Building

1890 N Revere Ct

Suite 6202

Mail Stop F411

Aurora, CO 80045


303-724-6653

Facebook Twitter LinkedIn
Additional Resources
  • CU Innovations
  • SPARK@Stanford
  • Other Funding Opportunities
  • Startup Toolbox
  • Contact Us
  • Website Feedback
  • CU System
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Accreditation
  • Employment
  • Give Now
 

© 2023 The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.

CMS Login

Webmail

UCD Access

Canvas

Opens in a new window Opens document in a new window